CAMBRIDGE, Massachusetts and BARCELONA, Spain, January 12, 2015 /PRNewswire/ --
Oryzon Genomics SA, a clinical stage biopharmaceutical company developing therapeutics in oncology and CNS diseases based on its proprietary epigenetics technology platform, today announced the appointment of...